SNCA and Parkinson disease: We could also find no significant differences in CSF or serum alpha-synuclein levels (only a small decrease of alpha-synuclein in PD patients) between the three groups emphasizing the potential diagnostic value of CIEF serpinA1 measurements for the discrimination between control, PD and PDD patients.